Tibab, Realyn .

HRN: 22-89-22  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/28/2026
CEFUROXIME 500MG (TAB)
02/28/2026
03/07/2026
PO
500 Mg
BID
S/P NSVD, PROM
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: